MicroRNA-21 Aggravates Cyst Growth in a Model of Polycystic Kidney Disease.

Citation data:

Journal of the American Society of Nephrology : JASN, ISSN: 1533-3450, Vol: 27, Issue: 8, Page: 2319-30

Publication Year:
Usage 8
Abstract Views 6
Link-outs 2
Captures 14
Readers 14
Social Media 1
Tweets 1
Citations 9
Citation Indexes 9
Lakhia, Ronak; Hajarnis, Sachin; Williams, Darren; Aboudehen, Karam; Yheskel, Matanel; Xing, Chao; Hatley, Mark E; Torres, Vicente E; Wallace, Darren P; Patel, Vishal
American Society of Nephrology (ASN)
Most Recent Tweet View All Tweets
article description
Autosomal dominant polycystic kidney disease (ADPKD), one of the most common monogenetic disorders, is characterized by kidney failure caused by bilateral renal cyst growth. MicroRNAs (miRs) have been implicated in numerous diseases, but the role of these noncoding RNAs in ADPKD pathogenesis is still poorly defined. Here, we investigated the role of miR-21, an oncogenic miR, in kidney cyst growth. We found that transcriptional activation of miR-21 is a common feature of murine PKD. Furthermore, compared with renal tubules from kidney samples of normal controls, cysts in kidney samples from patients with ADPKD had increased levels of miR-21. cAMP signaling, a key pathogenic pathway in PKD, transactivated miR-21 promoter in kidney cells and promoted miR-21 expression in cystic kidneys of mice. Genetic deletion of miR-21 attenuated cyst burden, reduced kidney injury, and improved survival of an orthologous model of ADPKD. RNA sequencing analysis and additional in vivo assays showed that miR-21 inhibits apoptosis of cyst epithelial cells, likely through direct repression of its target gene programmed cell death 4 Thus, miR-21 functions downstream of the cAMP pathway and promotes disease progression in experimental PKD. Our results suggest that inhibiting miR-21 is a potential new therapeutic approach to slow cyst growth in PKD.